450 results on '"García‐Azorín, David"'
Search Results
2. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey
3. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study
4. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
5. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
6. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
7. Increased MRI-based Brain Age in chronic migraine patients
8. Management of Headache Related to COVID-19
9. Structural brain changes in patients with persistent headache after COVID-19 resolution
10. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
11. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses
12. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
13. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance‐based study
14. Seizures and COVID-19: Results from the Spanish Society of Neurology’s COVID-19 registry
15. The cognitive impact of guard shifts in physicians: a before-after study
16. Headache education and management in Cameroon: a healthcare provider study
17. Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
18. Long COVID headache
19. Headache-related circuits and high frequencies evaluated by EEG, MRI, PET as potential biomarkers to differentiate chronic and episodic migraine: Evidence from a systematic review
20. Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients.
21. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
22. Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review
23. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti‐calcitonin gene‐related peptide therapies: The PREVENAC study
24. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions
25. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
26. Anosmia is associated with lower in-hospital mortality in COVID-19
27. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.
28. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine.
29. RE‐START: Exploring the effectiveness of anti‐calcitonin gene‐related peptide resumption after discontinuation in migraine.
30. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection
31. Effectiveness, tolerability and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
32. Association of dynamic and widespread mechanical sensitivity in cluster headache
33. Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study
34. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
35. Frequency and phenotype of headache in covid-19: a study of 2194 patients
36. Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients
37. Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study
38. Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain
39. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study.
40. Health equity, care access and quality in headache – part 1.
41. Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up
42. Multicentre Real-World Case-Control Study of Effectiveness, Tolerability, and Anti-Calcitonin Gene-Related Peptide Response Predictors in the Elderly
43. Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies
44. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses
45. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study
46. White matter changes in chronic and episodic migraine: a diffusion tensor imaging study
47. Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study
48. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant
49. Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome
50. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.